USD
$0.00
(0.00%
)At Close (As of Sep 15, 2025)
$65.52M
Market Cap
-
P/E Ratio
-2.57
EPS
$12.30
52 Week High
$1.30
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $652K |
Total Revenue | $652K |
Cost Of Revenue | - |
Costof Goods And Services Sold | - |
Operating Income | -$53M |
Selling General And Administrative | $15M |
Research And Development | $39M |
Operating Expenses | $54M |
Investment Income Net | - |
Net Interest Income | $1.3M |
Interest Income | $1.3M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.7M |
Income Before Tax | -$52M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$52M |
Comprehensive Income Net Of Tax | - |
Ebit | -$53M |
Ebitda | -$51M |
Net Income | -$52M |
Field | Value (USD) |
---|---|
Total Assets | $78M |
Total Current Assets | $66M |
Cash And Cash Equivalents At Carrying Value | $64M |
Cash And Short Term Investments | $64M |
Inventory | - |
Current Net Receivables | $108K |
Total Non Current Assets | $12M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $2.2M |
Other Non Current Assets | - |
Total Liabilities | $15M |
Total Current Liabilities | $9.6M |
Current Accounts Payable | $1.2M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $3.1M |
Total Non Current Liabilities | $5.6M |
Capital Lease Obligations | $8.6M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $8.6M |
Other Current Liabilities | $1.7M |
Other Non Current Liabilities | $2K |
Total Shareholder Equity | $63M |
Treasury Stock | - |
Retained Earnings | -$212M |
Common Stock | $2K |
Common Stock Shares Outstanding | $20M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$46M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $1.7M |
Capital Expenditures | $441K |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | -$441K |
Cashflow From Financing | $72M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$52M |
Field | Value (USD) |
---|---|
Gross Profit | $652K |
Total Revenue | $652K |
Cost Of Revenue | - |
Costof Goods And Services Sold | - |
Operating Income | -$53M |
Selling General And Administrative | $15M |
Research And Development | $39M |
Operating Expenses | $54M |
Investment Income Net | - |
Net Interest Income | $1.3M |
Interest Income | $1.3M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.7M |
Income Before Tax | -$52M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$52M |
Comprehensive Income Net Of Tax | - |
Ebit | -$53M |
Ebitda | -$51M |
Net Income | -$52M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
CalAmp Corp. The company is headquartered in Irvine, California.